Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Polarean logo — Revolutionize pulmonary medicine through direct visualizatio...

Polarean

Revolutionize pulmonary medicine through direct visualization of lung function.

Founded 2011 United States Durham, United States 28 employees Post-IPO Equity Total: $14.53M Health Care, Manufacturing +2

General Information

Company Name Polarean
Founded Year 2011
Location United States Durham, United States
Founders / Decision Makers
Team member
Employees 28
Industries Health Care, Manufacturing, Medical Devices +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Polarean. To contact Polarean, visit polarean.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Polarean

Polarean is a revenue-generating medical imaging technology company revolutionizing pulmonary medicine through direct visualization of lung function by introducing the power and safety of MRI to the respiratory healthcare community. This community is in desperate need of modern solutions to accurately assess lung function. The Company strives to optimize lung health and prevent avoidable loss by illuminating hidden disease, addressing the global unmet medical needs of more than 500 million patients worldwide suffering from chronic respiratory disease. Polarean is a leader in the field of hyperpolarization science and has successfully developed the first and only hyperpolarized Xenon MRI inhaled contrast agent, XENOVIEW™, which is now FDA-approved in the United States. Polarean is dedicated to researching, developing, and commercializing innovative imaging solutions with its noninvasive and radiation-free pulmonary functional MRI platform. This comprehensive drug-device platform encompasses the proprietary Xenon gas blend, gas hyperpolarization system, as well as software and accessories, facilitating fully integrated modern respiratory imaging operations. Founded in 2012, with offices in Durham, NC, and London, United Kingdom, Polarean is committed to increasing global awareness of and broad access to its XENOVIEW MRI technology platform. For the latest news and information about Polarean, please visit www.polarean.com.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $12.60M 10
William Blair
William Blair, Christopher von Jako +8
22 May 2024
Venture Round $1.93M -
24 Aug 2015

FAQ About Polarean

Revolutionize pulmonary medicine through direct visualization of lung function.
Polarean was founded in 2011.
Polarean is headquartered in Durham, United States.
Polarean operates in Health Care, Manufacturing, Medical Devices and Pharmaceutical.
Polarean has approximately 28 employees.
Polarean has completed 2 funding rounds, raising a total of $14.53M. The latest funding stage is Post-IPO Equity.

We're actively collecting intelligence on Polarean.

Source: BounceWatch company record for Polarean, https://bouncewatch.com/company/polarean, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes